Literature DB >> 17575671

Current use of steroids in management of abnormal raised skin scars.

M Jalali1, A Bayat.   

Abstract

Scars are a natural part of dermal healing processes and consist of networks of fibrous collagen tissue, laid down in response to injury to the dermis. In some genetically susceptible individuals, the process of scar tissue formation is excessive, and there is an over-secretion of collagen. This causes the formation of benign tumours (raised) scars known as keloid and hypertrophic scars. Scars can have many significant functional, cosmetic and psychological sequelae. Steroids are used therapeutically in the management of abnormal scars; however, this is associated with a variety of adverse effects. Their intralesional administration is the most widely used and most effective treatment modality for raised skin scars today. Despite this, our understanding of the way in which they work is poor and literature on the topic is, to date, lacking. Further work is needed to clarify the exact mechanisms that bring about abnormal scarring, to aid our understanding of the disease and facilitate the development of more evidence-based treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575671     DOI: 10.1016/s1479-666x(07)80045-x

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  15 in total

Review 1.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 2.  Current and Emerging Treatments for Postsurgical Cleft Lip Scarring: Effectiveness and Mechanisms.

Authors:  E Papathanasiou; C A Trotman; A R Scott; T E Van Dyke
Journal:  J Dent Res       Date:  2017-06-26       Impact factor: 6.116

3.  Human stem cells for craniomaxillofacial reconstruction.

Authors:  Morteza Jalali; William Niall Alexander Kirkpatrick; Malcolm Gregor Cameron; Siim Pauklin; Ludovic Vallier
Journal:  Stem Cells Dev       Date:  2014-04-02       Impact factor: 3.272

4.  Putting the Pieces Back Together: Optimizing Function and Appearance after Orbital Surgery.

Authors:  Kimberly Cockerham; Jacquelyn Laplant
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-22

5.  Towards the Development of a Device for Assessing the Pliability of Burn Scars.

Authors:  Francesco Dalle Mura; Lapo Governi; Rocco Furferi; Marta Cervo; Luca Puggelli
Journal:  Front Bioeng Biotechnol       Date:  2022-06-20

6.  Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms.

Authors:  Yuan Chu; Tao Chen; Hongqi Li; Pinghong Zhou; Yiqun Zhang; Weifeng Chen; Yunshi Zhong; Liqing Yao; Meidong Xu
Journal:  Surg Endosc       Date:  2018-08-31       Impact factor: 4.584

7.  A Translational Animal Model for Scar Compression Therapy Using an Automated Pressure Delivery System.

Authors:  A Alkhalil; S Tejiram; T E Travis; N J Prindeze; B C Carney; L T Moffatt; L S Johnson; J Ramella-Roman; J W Shupp
Journal:  Eplasty       Date:  2015-07-02

Review 8.  Update on hypertrophic scar treatment.

Authors:  Felipe Bettini Rabello; Cleyton Dias Souza; Jayme Adriano Farina Júnior
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

9.  Microplasma radiofrequency technology combined with triamcinolone improved the therapeutic effect on Chinese patients with hypertrophic scar and reduced the risk of tissue atrophy.

Authors:  Shui Yu; Hengjin Li
Journal:  Ther Clin Risk Manag       Date:  2016-05-10       Impact factor: 2.423

10.  Management of keloids and hypertrophic scars: current and emerging options.

Authors:  Gerd G Gauglitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.